134 related articles for article (PubMed ID: 3612693)
1. Synthesis and biological activities of arginine-vasopressin analogues with 4-hydroxyproline in position 7.
Buku A; Schwartz IL; Yamin N; Wyssbrod HR; Gazis D
J Med Chem; 1987 Aug; 30(8):1509-12. PubMed ID: 3612693
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antidiuretic and pressor activities of [arginine4]arginine-vasopressin and two related analogues.
Rekowski P; Lammek B; Melin P; Ragnarsson U; Kupryszewski G
Acta Chem Scand B; 1985; 39(6):453-7. PubMed ID: 4060959
[TBL] [Abstract][Full Text] [Related]
3. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
Buku A; Yamin N; Gazis D
Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
5. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
Lowbridge J; Manning M; Haldar J; Sawyer W
J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
[TBL] [Abstract][Full Text] [Related]
7. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
Varga C; Somlai C; Baláspiri L; László FA
Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
[TBL] [Abstract][Full Text] [Related]
8. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8.
Grzonka Z; Kasprzykowski F; Kojro E; Darlak K; Melin P; Fahrenholz F; Crause P; Boer R
J Med Chem; 1986 Jan; 29(1):96-9. PubMed ID: 2416923
[TBL] [Abstract][Full Text] [Related]
9. Influence of L-naphthylalanine in position 3 of AVP and its analogues on their pharmacological properties.
Lammek B; Czaja M; Derdowska I; Rekowski P; Trzeciak HI; Sikora P; Szkróbka W; Stojko R; Kupryszewski G
J Pept Res; 1997 Mar; 49(3):261-8. PubMed ID: 9151259
[TBL] [Abstract][Full Text] [Related]
10. Analogues of arginine vasopressin modified in position 2 or 3 with naphthylalanine: selective antagonists of oxytocin in-vitro.
Sobocińska M; Lempicka E; Konieczna E; Derdowska I; Lammek B; Melhem S; Kozik W; Janecka J; Janecki M; Trzeciak HI
J Pharm Pharmacol; 2000 Sep; 52(9):1105-12. PubMed ID: 11045891
[TBL] [Abstract][Full Text] [Related]
11. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
[TBL] [Abstract][Full Text] [Related]
12. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
Lempicka E; Slaninova J; Olma A; Lammek B
J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
Grzonka Z; Lammek B; Kasprzykowski F; Gazis D; Schwartz IL
J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
[TBL] [Abstract][Full Text] [Related]
15. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin.
Buku A; Yamin N; Gazis D
Int J Pept Protein Res; 1989 Jul; 34(1):28-32. PubMed ID: 2507457
[TBL] [Abstract][Full Text] [Related]
16. Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments.
Lammek B; Czaja M; Derdowska I; Lempicka E; Sikora P; Szkróbka W; Trzeciak HI
J Pept Res; 1998 Feb; 51(2):149-54. PubMed ID: 9516050
[TBL] [Abstract][Full Text] [Related]
17. Surprising pharmacological activity of analogues designed by substitution of position 3 in arginine vasopressin (AVP) and 8-D-arginine vasopressin with L-2-napthylalanine.
Lammek B; Konieczna E; Trzeciak HI; Kozłowski A; Szymkowiak J; Stojko R; Kupryszewski G
J Pharm Pharmacol; 1996 Mar; 48(3):316-9. PubMed ID: 8737061
[TBL] [Abstract][Full Text] [Related]
18. Antidiuretic and pressor activities of vasopressin analogs with L-alaninamide and D-alaninamide substitutions at position 9.
Buku A; Gazis D; Schwartz IL
Int J Pept Protein Res; 1984 May; 23(5):551-7. PubMed ID: 6547408
[TBL] [Abstract][Full Text] [Related]
19. Influence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological properties.
Sobolewski D; Prahl A; Derdowska I; Kwiatkowska A; Slaninová J; Lammek B
Protein Pept Lett; 2007; 14(3):213-7. PubMed ID: 17346223
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.
Kwiatkowska A; Sobolewski D; Prahl A; Borovicková L; Slaninová J; Lammek B
Eur J Med Chem; 2009 Jul; 44(7):2862-67. PubMed ID: 19418631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
